Preoperative Gadoxetic Acid-Enhanced MRI Based Nomogram Improves Prediction of Early HCC Recurrence After Ablation Therapy.

Frontiers in Oncology
Chengguang HuYuanping Zhou

Abstract

This study aimed to identify preoperative gadoxetic acid-enhanced MRI features and establish a nomogram for predicting early recurrence (≤ 2 years) of hepatocellular carcinoma (HCC) after ablation therapy. A total of 160 patients who underwent gadoxetic acid-enhanced MRI and ablation HCC therapy from January 2015 to June 2018, were included retrospectively and divided into a training cohort (n = 112) and a validation cohort (n = 48). Independent clinical risk factors and gadoxetic acid-enhanced MRI features associated with early recurrence were identified by univariate and multivariate logistic regression analysis and used for construction of a nomogram. The performance of the nomogram was evaluated by discrimination, calibration, and clinical utility. Alpha-fetoprotein (AFP) level, tumor number, arterial peritumoral enhancement, satellite nodule and peritumoral hypointensity at hepatobiliary phases in the training cohort were identified as independent risk factors for early recurrence after ablation. A new nomogram that was constructed with these five features showed an area under the curve (AUC) of 0.843 (95%CI 0.771-0.916) and 0.835 (95%CI 0.713-0.956) in the training and validation cohort, respectively. The calibration curv...Continue Reading

References

Nov 14, 2006·Medical Decision Making : an International Journal of the Society for Medical Decision Making·Andrew J Vickers, Elena B Elkin
Oct 5, 2010·Hepatology Research : the Official Journal of the Japan Society of Hepatology·Yusuke KawamuraHiromitsu Kumada
Nov 3, 2011·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Haeryoung KimYoung Nyun Park
Dec 3, 2014·Journal of Vascular and Interventional Radiology : JVIR·Muneeb Ahmed, UNKNOWN Technology Assessment Committee of the Society of Interventional Radiology
Apr 8, 2015·The Lancet Oncology·Vinod P BalachandranRonald P DeMatteo
Mar 30, 2017·The Cochrane Database of Systematic Reviews·Avik MajumdarKurinchi Selvan Gurusamy
Jun 13, 2017·Annals of Translational Medicine·Zhongheng Zhang, Michael W Kattan
Apr 10, 2018·Journal of Hepatology·UNKNOWN European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu, UNKNOWN European Association for the Study of the Liver
Apr 11, 2019·The New England Journal of Medicine·Augusto Villanueva
May 16, 2019·Cancer Imaging : the Official Publication of the International Cancer Imaging Society·Zhen ZhangBin Song
Aug 24, 2019·Nature Reviews. Gastroenterology & Hepatology·Ju Dong YangLewis R Roberts
Jan 28, 2020·Transplant International : Official Journal of the European Society for Organ Transplantation·Abdulahad Abdulrab Mohammed Al-AmeriXiao Xu

❮ Previous
Next ❯

Software Mentioned

pROC
PASS
RMS
SPSS
RMDA
R

Related Concepts

Related Feeds

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.

Adrenocortical Carcinoma

Hepatocellular carcinoma is the most common type of primary liver cancer and frequently occurs in individuals with chronic liver diseases like cirrhosis. Here is the latest research.